Effects of mid-jejunal compared to duodenal glucose infusion on peptide hormone release and appetite in healthy men

被引:24
作者
Chaikomin, Reawika [1 ]
Wu, Keng-Liang [1 ]
Doran, Selena [1 ]
Meyer, James H. [1 ]
Jones, Karen L. [1 ]
Feinle-Bisset, Christine [1 ]
Horowitz, Michael [1 ]
Rayner, Christopher K. [1 ]
机构
[1] Univ Adelaide, Discipline Med, Royal Adelaide Hosp, Adelaide, SA 5000, Australia
基金
澳大利亚国家健康与医学研究理事会; 英国医学研究理事会;
关键词
CCK; GLP-1; GIP; Incretin; Energy intake;
D O I
10.1016/j.regpep.2008.02.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Cells containing GIP and CCK predominate in the upper small intestine, while those containing GLP-1 are located more distally. Our aim was to compare the hormonal, glycemic and appetite responses to different sites of glucose delivery. Methods: Ten healthy males were each studied twice, in randomized order. A catheter was positioned with openings 15 cm beyond the pylorus ("duodenal"), and 100 cm beyond ("mid-jejunal"). On one day, glucose was infused into the duodenum (1 kcal/min) and saline into the mid-jejunum, for 90 min. On the other day, the infusion sites were reversed. Blood was sampled frequently, and hunger was scored by questionnaires. The tube was removed and energy intake measured from a buffet meal. Results: Stimulation of CCK and suppression of hunger were greater (each P < 0.05), and energy intake less (P = 0.05), with duodenal compared to mid-jejunal glucose infusion. Blood glucose, GIP, and insulin did not differ, and there was minimal GLP-1 increment on either day. Conclusions: There is regional variation in CCK, but not incretin hormone release, in the upper small intestine, and modest differences in the site of glucose exposure affect appetite and energy intake. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:38 / 42
页数:5
相关论文
共 49 条
[1]   HUMAN GUT HORMONE PROFILES IN PATIENTS WITH SHORT BOWEL SYNDROME [J].
ANDREWS, NJ ;
IRVING, MH .
DIGESTIVE DISEASES AND SCIENCES, 1992, 37 (05) :729-732
[2]   ROLE OF ENDOGENOUSLY RELEASED CHOLECYSTOKININ IN DETERMINING POSTPRANDIAL INSULIN LEVELS IN MAN - EFFECTS OF LOXIGLUMIDE, A SPECIFIC CHOLECYSTOKININ RECEPTOR ANTAGONIST [J].
BAUM, F ;
NAUCK, MA ;
EBERT, R ;
CANTOR, P ;
HOFFMANN, G ;
CHOUDHURY, AR ;
SCHMIDT, WE ;
CREUTZFELDT, W .
DIGESTION, 1992, 53 (3-4) :189-199
[3]   Loxiglumide, a CCK-A receptor antagonist, stimulates calorie intake and hunger feelings in humans [J].
Beglinger, C ;
Degen, L ;
Matzinger, D ;
D'Amato, M ;
Drewe, J .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2001, 280 (04) :R1149-R1154
[4]  
BUFFA R, 1976, GASTROENTEROLOGY, V70, P528
[5]   Initially more rapid small intestinal glucose delivery increases plasma insulin, GIP, and GLP-1 but does not improve overall glycemia in healthy subjects [J].
Chaikomin, R ;
Doran, S ;
Jones, KL ;
Feinle-Bisset, C ;
O'Donovan, D ;
Rayner, CK ;
Horowitz, M .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2005, 289 (03) :E504-E507
[6]  
Chapman IM, 1999, AM J CLIN NUTR, V69, P6
[7]   Upper limit for intestinal absorption of a dilute glucose solution in men at rest [J].
Duchman, SM ;
Ryan, AJ ;
Schedl, HP ;
Summers, RW ;
Bleier, TL ;
Gisolfi, CV .
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 1997, 29 (04) :482-488
[8]   ADAPTIVE-CHANGES IN THE PYLORIC MOTOR RESPONSE TO INTRADUODENAL DEXTROSE IN NORMAL SUBJECTS [J].
EDELBROEK, M ;
HOROWITZ, M ;
FRASER, R ;
WISHART, J ;
MORRIS, H ;
DENT, J ;
AKKERMANS, L .
GASTROENTEROLOGY, 1992, 103 (06) :1754-1761
[9]   GLUCAGON-LIKE PEPTIDE-1 CELLS IN THE GASTROINTESTINAL-TRACT AND PANCREAS OF RAT, PIG AND MAN [J].
EISSELE, R ;
GOKE, R ;
WILLEMER, S ;
HARTHUS, HP ;
VERMEER, H ;
ARNOLD, R ;
GOKE, B .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1992, 22 (04) :283-291
[10]   THE EFFECT OF TERMINAL ILEAL TRIGLYCERIDE INFUSION ON GASTRODUODENAL MOTILITY AND THE INTRAGASTRIC DISTRIBUTION OF A SOLID MEAL [J].
FONE, DR ;
HOROWITZ, M ;
READ, NW ;
DENT, J ;
MADDOX, A .
GASTROENTEROLOGY, 1990, 98 (03) :568-575